These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22664956)

  • 1. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
    Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.
    Straznicky NE; Lambert GW; Masuo K; Dawood T; Eikelis N; Nestel PJ; McGrane MT; Mariani JA; Socratous F; Chopra R; Esler MD; Schlaich MP; Lambert EA
    Am J Clin Nutr; 2009 Jan; 89(1):27-36. PubMed ID: 19056585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome.
    Straznicky NE; Lambert GW; McGrane MT; Masuo K; Dawood T; Nestel PJ; Eikelis N; Schlaich MP; Esler MD; Socratous F; Chopra R; Lambert EA
    Diabetes; 2009 May; 58(5):1126-32. PubMed ID: 19188428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA
    Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Cell dysfunction is associated with metabolic syndrome severity in adults.
    Malin SK; Finnegan S; Fealy CE; Filion J; Rocco MB; Kirwan JP
    Metab Syndr Relat Disord; 2014 Mar; 12(2):79-85. PubMed ID: 24283920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Lambert EA; Sari CI; Eikelis N; Nestel PJ; Phillips SE; Hering D; Karapanagiotidis S; Dixon JB; Schlaich MP; Lambert GW
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1544-50. PubMed ID: 25590214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
    Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Mariani JA; Kobayashi D; Hering D; Dixon JB; Lambert GW
    Front Physiol; 2016; 7():516. PubMed ID: 27857694
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
    Frontoni S
    Diabetes; 2013 Jan; 62(1):e1. PubMed ID: 23258917
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.
    Straznicky NE; Lambert EA; Lambert GW
    Diabetes; 2013 Jan; 62(1):e2. PubMed ID: 23258918
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of increased glucose on neurovascular dysfunction in patients with the metabolic syndrome.
    Rodrigues S; Cepeda FX; Toschi-Dias E; Dutra-Marques ACB; Carvalho JC; Costa-Hong V; Alves MJNN; Rondon MUPB; Bortolotto LA; Trombetta IC
    J Clin Hypertens (Greenwich); 2017 Sep; 19(9):840-847. PubMed ID: 28868764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes.
    George L; Bacha F; Lee S; Tfayli H; Andreatta E; Arslanian S
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2136-45. PubMed ID: 21508130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of endothelial function and sympathetic nervous system activity along the glucose continuum in individuals with differing metabolic risk profiles and low dietary sodium intake.
    Baqar S; Straznicky NE; Lambert G; Kong YW; Dixon JB; Jerums G; Ekinci EI; Lambert E
    BMJ Open Diabetes Res Care; 2019; 7(1):e000606. PubMed ID: 31114697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-diabetes in Italian obese children and youngsters.
    Brufani C; Fintini D; Ciampalini P; Nocerino V; Crea F; Giannone G; Patera PI; Valerio G; Cappa M; Barbetti F
    J Endocrinol Invest; 2011 Oct; 34(9):e275-80. PubMed ID: 21666412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects.
    Schumann U; Jenkinson CP; Alt A; Zügel M; Steinacker JM; Flechtner-Mors M
    PLoS One; 2017; 12(3):e0173803. PubMed ID: 28346464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.
    Gudbjörnsdottir S; Friberg P; Elam M; Attvall S; Lönnroth P; Wallin BG
    Blood Press; 1994 Nov; 3(6):394-403. PubMed ID: 7704288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.
    Peterson RG; Jackson CV; Zimmerman K; de Winter W; Huebert N; Hansen MK
    J Diabetes Res; 2015; 2015():487816. PubMed ID: 25961053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.